Clinical Trial Update: Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007) [Phase 2]

View source ↗

Summary

This Phase 2 dose-ranging study of MK0736 in patients with type 2 diabetes mellitus and hypertension was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• MK0736

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus, Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2013-12-11